Wednesday, June 22, 2011
Cryo-Cell International Shares Recognized in the Healthcare Services Industry for the Lowest Price to Earnings (P/E) Ratio
Key Comparative Indicator May Reflect Positive Potential for Continued Strong and Upward Trend of Cryo-Cell’s Stock Performance
Amplify’d from cryo-cell.com
Oldsmar, FL – June 21, 2011 – Cryo-Cell International, Inc. (OTCQX: CCEL) (the “Company”), one of the world’s largest and most established family cord blood banks and global industry leader in innovative stem cell solutions, announced today that it was evaluated by SmarTrend as among five companies in the Health Care Services industry with the lowest P/E ratios. According to SmarTrend, P/E is an important valuation tool when comparing companies in the same industry. A higher P/E ratio means that investors are paying more for each unit of net income, so the stock is more expensive compared to one with a lower P/E ratio. Cryo-Cell International has the lowest with a P/E of 7.0x. An article with SmarTrend’s analysis can be found at http://www.mysmartrend.com/news-briefs/news-watch/relatively-low-pe-ratio-health-care-services-industry-detected-shares-cryo-ce
See this Amp at http://bit.ly/jbXbVH
Enroll by midnight on June 26th, 2011!
Is Your Baby Due Soon? Expectant families can now extend healthcare protection with Cryo-Cell's exclusive Protect Baby, Protect Mom™ service. The program bundles our signature U-Cord with our exclusive Célle service and offers the best value.
Amplify’d from cryo-cell.com
Enroll by midnight on June 26th, 2011!
Is Your Baby Due Soon? Expectant families can now extend healthcare protection with Cryo-Cell's exclusive Protect Baby, Protect Mom™ service. The program bundles our signature U-Cord with our exclusive Célle service and offers the best value. The revolutionary Célle technology, discovered and launched by Cryo-Cell, empowers women to safely and easily collects potentially life-saving stem cells harvested from their own menstrual fluid. New mothers can complete their Célle service following the birth of their newborn once their monthly cycle resumes.
See this Amp at http://bit.ly/krtpn9
Monday, June 20, 2011
Umbilical cord stem cells prove themselves effective for lupus therapy
Umbilical cord links a baby to the mother that carries nutrients and gases for the growth of baby. Earlier a huge portion of the baby cord was used to be discarded and remaining part was used to dry off. Now as it has been understood that the umbilical cord blood stem cells are highly effective as well as useful to cure several severe diseases, doctors have started storing them. The cord is rich in two types of cells that are hematopoietic stem cells and mesenchymal cells. A research was done recently in Tampa on the effectiveness of the mesenchymal cells.
The study showed that such type of cells can also be used in the treatment of lupus nephritis; it was found when these cells were transplanted into the systemic lupus erythematosus or SLE mouse models. Systemic lupus erythematosus is indeed a disease with numerous aberrations in immune system and lupus nephritis found under clinical conditions. Lupus nephritis is actually a major cause of increasing death rate among SLE patients. The study was done by Taiwanese scientists whose results also have been published online in the Cell Transplantation publication.
The author of this online publication Dr. Oscar K. Lee is working in Medicine schools of National University of Yang -Ming. Dr Oscar told that mesenchymal cells possess the ability to modify the immune system which can alternate the immune responses. It will be possible by restricting the infection and also function of the cells, both mature and immature ones. These umbilical derived mesenchymal cells are now being explored to search for the effectiveness of treatments by these cells in the treatment of lupus nephritis. The study involved cord blood transplant of stem cells in the mice infused with some immune disorders that are exactly matching the SLE in the human beings.
Dr. Lee further notified some crucial results of their research. These include- umbilical mesenchymal cord cells interrupted the renal damage. It resulted into increase in the changes of renal pathology and protienuria development. Proteinruia is in actual the stage of presence of high level of protein serum in urine that shows the danger sign of renal deterioration. It is not only this; the level of certain antibodies was also reduced. Researchers found a big positive difference in the survival rate of mice that were provided treatment at the age of two months and those which were treated at the age of six months. The whole research led the scientists to conclude that uMSCs can be very effective.
The canvassers also concluded that the use of mesenchymal stem cells taken from allergenic donor that is those obtained from others were compatible as compared to those that are autologous donors obtained from own body. It was a major triumph by the scientists. The study provided a complete solution for the auto immune rejection problems. It would be used for the further exploration of using these umbilical cord stem cells against several diseases especially Lupus nephritis. Although stem cells are found in the placenta but due to controversy linked to this, scientists are more involved in doing research on stem cells extracted from baby cord blood.
Provia laboratories involved in stem cells extraction from tooth other than cord blood stem cells
A Provia laboratory LLC is a modern bio-banking organization that is soon going to become high tech with more and more innovative practices. Located in Lexington, the company professionals give promise to discover a regenerative medicine. This medicine will be used effectively for the treatment of those who are physically handicapped or have some damaged organ. With the help of drugs one day it will be possible to grow a lost appendage or some damaged body organ simply by the exchange of one tooth. It is because the company is engaged into harvesting stem cells from the baby teeth rather than extracting cord blood stem cells.
Later on, it will be possible for the owner to access the stem cells in future when they would be in need to regenerate a limb. The business model of the company exactly matches the strategies of other companies which are actively involved in the collection of cord blood during the birth of new born. According to Howard Green man, the Chief Executive, the average cord blood banking cost is approximately fifteen hundred dollars directly making annual payments of one hundred and fifty dollars in other companies. While costs charged in Provia would be about six hundred and forty nine dollars direct and thus annual charges of one hundred and twenty dollars.
This medicine with the regenerative capacity basically allows for the collection and also the storage of stem cells of an individual. It is another fact that these medicines would only be used by those persons who are either family members or blood relatives. The reason behind this it is necessary that there should be a genetic match between cells and recipient. if the matching between donor and acceptor would be perfect then there would be no chance for the new appendage or any organ to get rejected. The logic behind this is the new limb has been originated in fact from the DNA of the person himself.
Nowadays, the concept of regenerative medicine is completely new. stem cells obtained from different parts of the body such as umbilical cord blood collection grow into different cells and are fully effective to cure several diseases. Similarly the stem cells extracted from the tooth can be used to grow bones in the jaw. Moreover, they can also be used to grow some cells similar to pancreas which would be able to develop insulin. Researchers from all around the world are confident that in a very short time it would be possible to obtain stem cells from other parts of the body. These cells will then be used for the treatment of large segment of population in the whole universe to generate appendages and damaged organs.
The company has already its dealing in America, Venezuela, Panama, Costa Rica, Guatemala and Ecuador. Greenman said that the organization named Cordon de Vida will be doing teeth collection and transportation for Provia. Provia will be then involved in stem cell harvesting and their storage. This issue is catching high interest of the scientists and people even outside America. Provia Laboratories is thus proving to be a tooth angel of the modern world because of its wonderful contribution.
Now feel secure with new storage place of umbilical cord blood donation
The scientists from all around the world today fully acknowledge the importance of umbilical cord. This is the reason that the cord that was earlier considered as waste and used to be discarded is now being preserved. Scientists now ask parents to donate cord blood so that it can be used for the treatment of several diseases for their child. The baby cord blood is preserved in the blood banks especially made for this purpose. Recently, a new bank has been opened in Melbourne that would be operating on a large scale.
These banks are generally of two types – private owned and public. This recently opened institution is privately owned. Privately owned cord banks are those that are run either by a private organization or an individual. Such institutions collect the blood regardless of any medical reason and they also charge fixed prices. According to an estimate, this new establishment will charge about three thousand dollars for the storage of blood stem cells up to a period of eighteen years. Peter Littlewood, Cell Care Australia Chief Executive said that the stem cells present in the umbilical cord blood have the potential to cure several diseases.
The cells obtained from these can be used to determine the cure for diseases such as Cerebral Palsy. The main benefit of carrying umbilical cord storage is because it possesses a large quantity of cells. Among these, it also contains some stem cells which have already proved their effectiveness for many disorders and thus hold high value for the healthy future. Under this recently opened Melbourne bank of cord blood, the cells will be available only for private use. They will not be distributed to anyone who is in need, not exactly like the publicly owned facilities. Under the public cord blood banking system such banks run their operations under the government.
There are no charges for the collection and further preservation of the umbilical cord. The blood donated for the storage in the public banks is sent to the general database. A major disadvantage of this system is that there are fewer chances to find a match of stem cells at the time of emergency. The private banks are just like insurance for the new born and family members. This is one of the major differences between these two types of banks where private provide more security as compared to publicly owned banks. If any person wants to go for umbilical cord blood donation, then they will surely feel secure to donate it to private banks.
The main reason behind it is these facilities provide efficient services of storage of cord blood and further preserving the individual sample for the use of concerned person. While looking for the cord blood in public bank, it has to be made sure that there is perfect match between the HLA antigens of the recipient and donor body. When we, compare cord blood banks one will find that with the opening of a private bank operating on large scale, more families would be doing insurance for their child’s health.
Today’s cord blood banks of Russia are demanding more samples for cord blood transplant
It is not a big issue to help others in need especially when it saves others’ life. USA mothers are more concerned for the safe future of their babies. They are actively participating in cord blood donation and their banking during the birth of their baby. This phase is in actual an early stage of the cord blood banking. During this process the cells are extracted from the umbilical cord at the time of birth of the baby. These are stored under very low temperature conditions that is up to one ninety degree. However people in other countries are not much aware about the significance of donation of umbilical cord.
This is why many countries are still facing lack of cord blood. The blood bank of Russia recently urged for the need of about 300,000 to 400,000 blood samples for the transplantation. It was notified by the Federal Clinical Scientific Centre of Child Hematology, Immunology and Oncology, Deputy Director, Alexei Maschan. Maschan further analyzed the number of advantages provided by the cord blood transplant. They are easily available due to easy extraction from the umbilical cord. On the other hand the extraction from the bone marrow is difficult.
In the current time, there are two banks that are publicly owned for deriving stem cells by baby cord. One is in Moscow and the other is in Samara. Both of the banks have been registered under the umbilical blood bank of Europe which has the collection of some of the typical stem cells. In the present time samples of cord blood are not exceeding ten thousand in each of the bank. It is an amazing fact that the harvesting of cord blood is done within thirty seconds of the birth of the baby. The cord is simply clamped and then there is made an incision.
After this the cord is then transferred to the laboratory for cryopreservation. Further, umbilical cord blood donation does not cause any harm to mother or baby and has only proved beneficial for the scientists for various studies. Surgeons do not need large amount of cord for the storage. The average blood required is seventy-five milliliters or one by third cup. There is a different procedure for the processing of the cord blood. Some go for separation of the red blood cells and discard them while some others do not. It has been found that both of the methods of processing are equally effective in stem cells harvesting.
The blood bank at Moscow every year receives about hundred of requests for the transplantations but it only provides about seven to ten cord blood samples. Same is the case with Samara cord blood bank. According to director of Samara clinical center Olga Tyumina the Samara blood bank received hundred requests and has managed six cord blood transplantation. Further the banking process is safe and completely secure. Moreover with advancement in science the practices have further become safer. The banking process would further be useful to cure many blood disorders, genetic and immune disorders. So, feel safe to donate for the healthy future of the baby.
Subscribe to:
Posts (Atom)